Cumulative electroconvulsive therapy sessions and focal epilepsy: A nationwide cohort study in Japan

Epilepsia Open · Published 2026-07-29 · DOI 10.1002/epi4.70313

Free full text

Authors (5)

Masahiro Hata, Yuki Miyazaki, Hisaki Omori, Shun Takahashi, Manabu Ikeda

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Hata, M., Miyazaki, Y., Omori, H., et al. (2026). Cumulative electroconvulsive therapy sessions and focal epilepsy: A nationwide cohort study in Japan. Epilepsia Open. https://doi.org/10.1002/epi4.70313

Related articles

• ILAE ‐ YES global webinar series: Integrating clinical and basic science in epilepsy research · Epilepsia Open · 2026 · Same journal
• KCNQ2 neonatal epilepsy: Impact of prompt diagnosis and treatment, and early predictors of outcome severity · Epilepsia Open · 2026 · Same journal
• Trends in antiseizure medication monotherapy for pediatric epilepsy in the United States · Epilepsia Open · 2026 · Same journal
• Incidence and outcomes of childhood status epilepticus in Kano, northern Nigeria · Epilepsia Open · 2026 · Same journal
• Epilepsia open —April 2026 announcements · Epilepsia Open · 2026 · Same journal
• The Global Epilepsy Needs Study ( GENS ): A mixed‐methods, multi‐country exploration of the unmet psychosocial and everyday needs of people with epilepsy · Epilepsia Open · 2026 · Same journal
• Changes in effectiveness and safety in patients with Lennox–Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open‐label extension study · Epilepsia Open · 2026 · Same journal
• Computational protein stability analysis of SCN1A missense variants reveals domain‐dependent stability patterns · Epilepsia Open · 2026 · Same journal
• Artificial intelligence in the assessment of epilepsy‐related genetic mutations: Learned from GABA A receptors and GABA transporter 1 · Epilepsia Open · 2026 · Same journal
• Effectiveness of adjunctive low‐dose clobazam in adults with focal drug‐resistant epilepsy and incomplete response to cenobamate: A real‐world study · Epilepsia Open · 2026 · Same journal